Optimization of a fibrin scaffold for sustained release of an adenoviral gene vector
โ Scribed by Ailish Breen; Padraig Strappe; Anil Kumar; Timothy O'Brien; Abhay Pandit
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 291 KB
- Volume
- 78A
- Category
- Article
- ISSN
- 1549-3296
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
One of the major limitations of adenovirus as an efficient gene delivery vehicle is its transient nature of transgene expression. At present, no biodegradable release system exists that permits the sustained release of gene delivery. This study aimed to optimize a biodegradable fibrin scaffold for sustained adenoviral mediated gene delivery. Scaffold formulations were fabricated incorporating an adenoviral vector encoding ฮฒโgalactosidase, and each scaffold was incubated in elution fluid. The level of transfection of cells was measured to assess virus diffusion from each scaffold at different time periods. Results showed that viral particles were present in the elution fluid and had the ability to transfect cells at different time points. Depending on the scaffold formulation, variable rates of diffusion were seen. Analysis of scaffold microarchitecture using stereo pairs showed that variable pore depth is seen in different fibrin scaffold concentration, which may be a determining factor in the diffusion rate. It was concluded that sustained release of the adenovirus could be attained up to 192 h at the optimal concentration of 60 mg/mL fibrinogen and 4 IU thrombin. ยฉ 2006 Wiley Periodicals, Inc. J Biomed Mater Res, 2006
๐ SIMILAR VOLUMES
## Abstract ## Background Cereproยฎ (sitimagene ceradenovec) is an adenoviral vector containing herpes simplex virus thymidine kinase gene (HSVโtk), which is being developed for the treatment of highโgrade glioma with oral ganciclovir (GCV). The nonclinical safety and biodistribution of Cereproยฎ we
The release rate of 5-fluorouracil (5-FU) from lipid-coated nanoparticles (LNPs) was determined to develop a respirable delivery system for use as adjuvant (postsurgery) therapy for lung cancer. LNPs were prepared by spray drying, and the in vitro release was measured by microdialysis. The compositi
## METHODS. Human ovarian cancer cells (SKOV3.ip1) were infected in vitro with AdCMVGRPr and were assayed for receptor expression at 2, 4, and 7 days after 2 Department of Medicine, Comprehensive Caninfection by using a radiolabeled bombesin-binding assay. Biodistribution studies cer Center, Unive
## Abstract ## Background Although human islet transplantation is a promising approach for treating type I diabetes, its success is limited as a result of the poor survival rate of transplanted islets. Expression of a growth factor gene to promote revascularization and silencing of proโapoptotic g